JACOBS LEVY EQUITY MANAGEMENT, INC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2021$632,000
+12.5%
158,455
+20.7%
0.00%0.0%
Q2 2021$562,000
+0.9%
131,300
-0.1%
0.00%0.0%
Q1 2021$557,000
-25.7%
131,423
-32.0%
0.00%
-42.9%
Q4 2020$750,000
+20.4%
193,398
+25.1%
0.01%
+16.7%
Q3 2020$623,000
+37.2%
154,650
+45.0%
0.01%
+20.0%
Q2 2020$454,000
+34.7%
106,646
+32.9%
0.01%
+25.0%
Q1 2020$337,000
+105.5%
80,218
+92.6%
0.00%
+100.0%
Q4 2019$164,00041,6550.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,018,00094.79%
TANG CAPITAL MANAGEMENT LLC 9,405,490$39,879,00011.22%
RTW INVESTMENTS, LP 2,327,903$9,870,0000.15%
Boxer Capital, LLC 890,700$3,777,0000.13%
FIRST MIDWEST BANK TRUST DIVISION 89,341$379,0000.05%
WealthTrust Axiom LLC 30,400$128,0000.04%
PREMIER ASSET MANAGEMENT LLC 51,305$217,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 18,113$77,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 39,000$165,0000.02%
Inscription Capital, LLC 10,000$42,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders